Yantai Lnc Biotechnology Singapore Pte. Ltd.

This early-stage study tested a new radioactive drug called 177Lu-LNC1004 in 11 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the drug is safe and to find the best dose for future studies. Participants received up to 4 d…

This early-phase trial tested the safety of a new imaging agent called 68Ga-LNC1007 in 8 adults—some healthy and some with solid tumors. Participants received a single injection and were monitored for side effects and how the agent moved through the body. The goal was to see if i…

This early-phase trial tested a new radioactive imaging agent called 18F-LNC1007 in 8 people—some healthy and some with a small number of cancer lesions. The goal was to see how the agent moves through the body, how much radiation it gives off, and whether it is safe. Participant…